Welcome Message


Distinguished members of the Korean Urological Oncology Society!

The Korean Urological Oncology Society originally started as the ‘Urological Cancer Research Society’ in 1988, and began official activities as the ‘Korean Urological Oncology Society’ in 1991. Over the past three decades, our society has time and again succeeded in making great strides in the field of urological oncology.Even in difficult situations, the dedication and committed efforts of formerchairmen, standing directors, general directors and various members of our society, has lead our society to grow into a leading society in the field of urology. As a member who has been alongside this society’s journey, and as the president of this society, I will do my best to uphold the status of the Korean Urological Oncology Society with honor and a sense of duty during my term in office.

I would like to further develop the regular academic competition, the Multidisciplinary Conference (MDC) and the East Asia Urologic Oncology Symposium (EAUOS), and continue our overseas short-term training support program for competent young members.

The Korean Journal of Urological Oncology was promoted to an official journal of the Korean Research Foundation in 2017.We will endeavor to greater extent in order to escalate to a SCI journal, raising the status of The Korean Urological Oncology Society at home and abroad.

We plan to provide infinite support to the Prostate, Kidney, and Bladder Cancer Research Groups, and also to large-scale prospective researches led by these communities. We would like to create a high-quality research platform for urologic oncolgistsin which their achievements may reach greater heights.

We will continue to revise the guidelines for prostate cancer, renal cancer and bladder cancer to help with treatment, research, and insurance, and continue to revise the patient management guidelines to reflect reality. In addition, with the momentum of the successful development of prostate cancer treatment recommendations and certification by the Korean Medical Association, we plan to develop recommendations for bladder cancer and renal cancer as well. In line with the many advancements that our society has accomplished, we will make efforts to reorganize the society's rules and regulations, and to preserve all records associated with it’s management.

This society exists through the presence of its members. I will create a venue where our members can easily participate in activities and communicate with each other, and generate a virtuous cycle in which our members can grow and our society can be advanced by the participation of our members.

I ask for your continuous interest and participation which is the beating heart and foundation this society has been built upon.

I wish all the members of this society happiness. Thank you.

Sun Il Kim
President of the Korean Urological Oncology Society